| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2024 ( Subtotal = $7,615,192 ) |
| | 2024 | 2024 | VERSITI WISCONSIN, INC. | 638 N 18TH ST | MILWAUKEE | WI | 53233-2121 | MILWAUKEE | USA | K99HL163412 | Pre-mRNA Processing and Function of Alternatively Spliced Isoforms of TFPI | 000 | 2 | NIH | 4/15/2024 | $116,334 |
| | 2024 | 2024 | VERSITI WISCONSIN, INC. | 638 N 18TH ST | MILWAUKEE | WI | 53233-2121 | MILWAUKEE | USA | R01HL169144 | Interrogating clinically relevant attributes of maternal alloimmunity in fetal/neonatal alloimmune thrombocytopenia | 000 | 1 | NIH | 4/25/2024 | $420,866 |
| | 2024 | 2024 | VERSITI WISCONSIN, INC. | 638 N 18TH ST | MILWAUKEE | WI | 53233-2121 | MILWAUKEE | USA | T32HL170989 | Training in Transfusion Medicine and Classical Hematology | 000 | 1 | NIH | 4/30/2024 | $81,547 |
| | 2024 | 2024 | VERSITI WISCONSIN, INC. | 638 N 18TH ST | MILWAUKEE | WI | 53233-2121 | MILWAUKEE | USA | R01HL157893 | Endothelial Rap1 in the control of heart function | 000 | 3 | NIH | 12/22/2023 | $664,924 |
| | 2024 | 2024 | VERSITI WISCONSIN, INC. | 638 N 18TH ST | MILWAUKEE | WI | 53233-2121 | MILWAUKEE | USA | R01HL160861 | Kindlin-3 signaling in neutrophils | 000 | 3 | NIH | 1/19/2024 | $411,992 |
| | 2024 | 2024 | VERSITI WISCONSIN, INC. | 638 N 18TH ST | MILWAUKEE | WI | 53233-2121 | MILWAUKEE | USA | R01HL161127 | B-cell response and thrombotic complications in COVID-19 | 000 | 3 | NIH | 2/7/2024 | $593,885 |
| | 2024 | 2024 | VERSITI WISCONSIN, INC. | 638 N 18TH ST | MILWAUKEE | WI | 53233-2121 | MILWAUKEE | USA | R01HL157309 | Kindlin-3 signaling in platelets | 000 | 3 | NIH | 1/23/2024 | $532,524 |
| | 2024 | 2024 | VERSITI WISCONSIN, INC. | 638 N 18TH ST | MILWAUKEE | WI | 53233-2121 | MILWAUKEE | USA | P01HL151333 | Molecular and Clinical Glycobiology of the Bone Marrow Environment | 000 | 4 | NIH | 12/18/2023 | $2,213,925 |
| | 2024 | 2024 | VERSITI WISCONSIN, INC. | 638 N 18TH ST | MILWAUKEE | WI | 53233-2121 | MILWAUKEE | USA | R01CA257602 | Strategies to target BCR-ABL1 compound mutants in CML and Ph+ ALL | 001 | 4 | NIH | 4/17/2024 | $18,872 |
| | 2024 | 2024 | VERSITI WISCONSIN, INC. | 638 N 18TH ST | MILWAUKEE | WI | 53233-2121 | MILWAUKEE | USA | R01CA257602 | Strategies to target BCR-ABL1 compound mutants in CML and Ph+ ALL | 000 | 4 | NIH | 12/29/2023 | $339,694 |
| | 2024 | 2024 | VERSITI WISCONSIN, INC. | 638 N 18TH ST | MILWAUKEE | WI | 53233-2121 | MILWAUKEE | USA | K08HL146941 | The role in inflammation in platelet activation and thrombosis | 000 | 5 | NIH | 1/23/2024 | $162,043 |
| | 2024 | 2024 | VERSITI WISCONSIN, INC. | 638 N 18TH ST | MILWAUKEE | WI | 53233-2121 | MILWAUKEE | USA | R01CA268496 | The function of MS4A3 in normal and malignant hematopoiesis | 001 | 2 | NIH | 4/17/2024 | $31,180 |
| | 2024 | 2024 | VERSITI WISCONSIN, INC. | 638 N 18TH ST | MILWAUKEE | WI | 53233-2121 | MILWAUKEE | USA | R01CA268496 | The function of MS4A3 in normal and malignant hematopoiesis | 000 | 2 | NIH | 12/21/2023 | $561,224 |
| | 2024 | 2024 | VERSITI WISCONSIN, INC. | 638 N 18TH ST | MILWAUKEE | WI | 53233-2121 | MILWAUKEE | USA | R01HL089224 | Carbohydrate-Mediated Platelet Clearance | 000 | 16 | NIH | 1/23/2024 | $521,930 |
| | 2024 | 2024 | VERSITI WISCONSIN, INC. | 638 N 18TH ST | MILWAUKEE | WI | 53233-2121 | MILWAUKEE | USA | R35HL139937 | Basic Investigation and Translational Applications Concerning the Cell and Molecular Biology of Blood and Vascular Cells | 000 | 7 | NIH | 3/4/2024 | $887,912 |
| | 2024 | 2023 | VERSITI WISCONSIN, INC. | 638 N 18TH ST | MILWAUKEE | WI | 53233-2121 | MILWAUKEE | USA | R01HL130724 | B cell responses in heparin-induced thrombocytopenia | 000 | 7 | NIH | 1/3/2024 | $0 |
| | 2024 | 2023 | VERSITI WISCONSIN, INC. | 638 N 18TH ST | MILWAUKEE | WI | 53233-2121 | MILWAUKEE | USA | K01DK125617 | Molecular Mechanism of Sickle Cell Hepatic Crisis | 001 | 5 | NIH | 3/12/2024 | $74,830 |
| | 2024 | 2022 | VERSITI WISCONSIN, INC. | 638 N 18TH ST | MILWAUKEE | WI | 53233-2121 | MILWAUKEE | USA | F30CA236322 | Cohesin Mutations in Core-Binding Factor Acute Myeloid Leukemia | 000 | 4 | NIH | 4/24/2024 | -$4,550 |
| | 2024 | 2021 | VERSITI WISCONSIN, INC. | 638 N 18TH ST | MILWAUKEE | WI | 53233-2121 | MILWAUKEE | USA | R01HL139847 | Molecular Interactions of FVIII and VWF | 000 | 4 | NIH | 10/23/2023 | $0 |
| | 2024 | 2021 | VERSITI WISCONSIN, INC. | 638 N 18TH ST | MILWAUKEE | WI | 53233-2121 | MILWAUKEE | USA | R56AI159536 | The cellular mechanisms of immunological memory development in COVID-19 patients | 000 | 1 | NIH | 12/11/2023 | -$13,940 |
| | 2024 | 2021 | VERSITI WISCONSIN, INC. | 638 N 18TH ST | MILWAUKEE | WI | 53233-2121 | MILWAUKEE | USA | R01HL136430 | VWF - Mechanisms of Regulation | 000 | 4 | NIH | 1/26/2024 | $0 |
| | 2024 | 2021 | VERSITI WISCONSIN, INC. | 638 N 18TH ST | MILWAUKEE | WI | 53233-2121 | MILWAUKEE | USA | R01CA204231 | Cohesin Mutations in Acute Myelogenous Leukemia | 000 | 5 | NIH | 2/28/2024 | $0 |
|
| Issue Date FY: 2023 ( Subtotal = $14,661,789 ) (Continued on the next page) |
| | 2023 | 2023 | VERSITI WISCONSIN, INC. | 638 N 18TH ST | MILWAUKEE | WI | 53233-2121 | MILWAUKEE | USA | R01HL089224 | Carbohydrate-Mediated Platelet Clearance | 000 | 15 | NIH | 1/16/2023 | $516,972 |
| | 2023 | 2023 | VERSITI WISCONSIN, INC. | 638 N 18TH ST | MILWAUKEE | WI | 53233-2121 | MILWAUKEE | USA | R35HL139937 | Basic Investigation and Translational Applications Concerning the Cell and Molecular Biology of Blood and Vascular Cells | 001 | 6 | NIH | 5/22/2023 | $0 |
| | 2023 | 2023 | VERSITI WISCONSIN, INC. | 638 N 18TH ST | MILWAUKEE | WI | 53233-2121 | MILWAUKEE | USA | R35HL139937 | Basic Investigation and Translational Applications Concerning the Cell and Molecular Biology of Blood and Vascular Cells | 000 | 6 | NIH | 4/21/2023 | $986,569 |
| | 2023 | 2023 | VERSITI WISCONSIN, INC. | 638 N 18TH ST | MILWAUKEE | WI | 53233-2121 | MILWAUKEE | USA | K99HL163412 | Pre-mRNA Processing and Function of Alternatively Spliced Isoforms of TFPI | 000 | 1 | NIH | 4/13/2023 | $116,334 |
| | 2023 | 2023 | VERSITI WISCONSIN, INC. | 638 N 18TH ST | MILWAUKEE | WI | 53233-2121 | MILWAUKEE | USA | R01CA254354 | Targeting the Metabolic Regulator SIRT5 in Acute Myeloid Leukemia | 000 | 5 | NIH | 7/11/2023 | $369,889 |
| | 2023 | 2023 | VERSITI WISCONSIN, INC. | 638 N 18TH ST | MILWAUKEE | WI | 53233-2121 | MILWAUKEE | USA | R01CA254354 | Targeting the Metabolic Regulator SIRT5 in Acute Myeloid Leukemia | 001 | 5 | NIH | 8/28/2023 | $371,250 |
| | 2023 | 2023 | VERSITI WISCONSIN, INC. | 638 N 18TH ST | MILWAUKEE | WI | 53233-2121 | MILWAUKEE | USA | R01HL161127 | B-cell response and thrombotic complications in COVID-19 | 000 | 2 | NIH | 2/22/2023 | $659,871 |
| | 2023 | 2023 | VERSITI WISCONSIN, INC. | 638 N 18TH ST | MILWAUKEE | WI | 53233-2121 | MILWAUKEE | USA | R01HL166382 | Understanding and Controlling the Contribution of Fibrinolysis to Bleeding Using a Long-Acting Antifibrinolytic RNA Therapy | 000 | 1 | NIH | 8/15/2023 | $757,275 |
| | 2023 | 2023 | VERSITI WISCONSIN, INC. | 638 N 18TH ST | MILWAUKEE | WI | 53233-2121 | MILWAUKEE | USA | R01HL157309 | Kindlin-3 signaling in platelets | 000 | 2 | NIH | 1/6/2023 | $532,524 |
| | 2023 | 2023 | VERSITI WISCONSIN, INC. | 638 N 18TH ST | MILWAUKEE | WI | 53233-2121 | MILWAUKEE | USA | R01HL157309 | Kindlin-3 signaling in platelets | 001 | 2 | NIH | 3/3/2023 | $59,169 |
| | 2023 | 2023 | VERSITI WISCONSIN, INC. | 638 N 18TH ST | MILWAUKEE | WI | 53233-2121 | MILWAUKEE | USA | R01CA257602 | Strategies to target BCR-ABL1 compound mutants in CML and Ph+ ALL | 001 | 3 | NIH | 9/14/2023 | $30,195 |
| | 2023 | 2023 | VERSITI WISCONSIN, INC. | 638 N 18TH ST | MILWAUKEE | WI | 53233-2121 | MILWAUKEE | USA | R01CA257602 | Strategies to target BCR-ABL1 compound mutants in CML and Ph+ ALL | 000 | 3 | NIH | 1/6/2023 | $339,694 |
| | 2023 | 2023 | VERSITI WISCONSIN, INC. | 638 N 18TH ST | MILWAUKEE | WI | 53233-2121 | MILWAUKEE | USA | R37CA229751 | The histone demethylase JMJD1C in human Acute Myeloid Leukemia | 000 | 5 | NIH | 4/24/2023 | $373,265 |
| | 2023 | 2023 | VERSITI WISCONSIN, INC. | 638 N 18TH ST | MILWAUKEE | WI | 53233-2121 | MILWAUKEE | USA | K08HL146941 | The role in inflammation in platelet activation and thrombosis | 000 | 4 | NIH | 11/23/2022 | $162,043 |
| | 2023 | 2023 | VERSITI WISCONSIN, INC. | 638 N 18TH ST | MILWAUKEE | WI | 53233-2121 | MILWAUKEE | USA | R01HL130724 | B cell responses in heparin-induced thrombocytopenia | 000 | 7 | NIH | 8/25/2023 | $645,343 |
| | 2023 | 2023 | VERSITI WISCONSIN, INC. | 638 N 18TH ST | MILWAUKEE | WI | 53233-2121 | MILWAUKEE | USA | R01HL131836 | Structural Transition of Cellular Integrins and Applications Thereof | 000 | 8 | NIH | 7/14/2023 | $560,922 |
| | 2023 | 2023 | VERSITI WISCONSIN, INC. | 638 N 18TH ST | MILWAUKEE | WI | 53233-2121 | MILWAUKEE | USA | R01CA268496 | The function of MS4A3 in normal and malignant hematopoiesis | 000 | 1 | NIH | 12/30/2022 | $466,620 |
| | 2023 | 2023 | VERSITI WISCONSIN, INC. | 638 N 18TH ST | MILWAUKEE | WI | 53233-2121 | MILWAUKEE | USA | R01HL160861 | Kindlin-3 signaling in neutrophils | 000 | 2 | NIH | 1/27/2023 | $457,769 |
| | 2023 | 2023 | VERSITI WISCONSIN, INC. | 638 N 18TH ST | MILWAUKEE | WI | 53233-2121 | MILWAUKEE | USA | R01HL157893 | Endothelial Rap1 in the control of heart function | 000 | 2 | NIH | 1/23/2023 | $738,805 |
| | 2023 | 2023 | VERSITI WISCONSIN, INC. | 638 N 18TH ST | MILWAUKEE | WI | 53233-2121 | MILWAUKEE | USA | R01GM137143 | Structural Mechanisms Underlying the Activity Regulation of the Receptor-like Protein Tyrosine Phosphatase, CD148/PTPRJ | 000 | 4 | NIH | 4/24/2023 | $330,000 |
| | 2023 | 2023 | VERSITI WISCONSIN, INC. | 638 N 18TH ST | MILWAUKEE | WI | 53233-2121 | MILWAUKEE | USA | R01AI160244 | Development of a B Cell Therapeutic | 000 | 4 | NIH | 8/4/2023 | $678,278 |
| | 2023 | 2023 | VERSITI WISCONSIN, INC. | 638 N 18TH ST | MILWAUKEE | WI | 53233-2121 | MILWAUKEE | USA | R01HL149364 | TFPI, Protein S, and Plasma FIXa in Hormone-Induced Hypercoagulability | 000 | 3 | NIH | 8/15/2023 | $695,817 |
| | 2023 | 2023 | VERSITI WISCONSIN, INC. | 638 N 18TH ST | MILWAUKEE | WI | 53233-2121 | MILWAUKEE | USA | P01HL151333 | Molecular and Clinical Glycobiology of the Bone Marrow Environment | 000 | 3 | NIH | 12/15/2022 | $2,459,915 |
| | 2023 | 2023 | VERSITI WISCONSIN, INC. | 638 N 18TH ST | MILWAUKEE | WI | 53233-2121 | MILWAUKEE | USA | P01HL144457 | Zimmerman Program on the Biology of VWD | 000 | 5 | NIH | 6/8/2023 | $2,629,473 |
| | 2023 | 2023 | VERSITI WISCONSIN, INC. | 638 N 18TH ST | MILWAUKEE | WI | 53233-2121 | MILWAUKEE | USA | F30CA246920 | Reprogramming tumor-reactive CD8 T cells by targeting the IL-21-BATF pathway to treat melanoma | 001 | 4 | NIH | 5/22/2023 | $942 |
| | 2023 | 2023 | VERSITI WISCONSIN, INC. | 638 N 18TH ST | MILWAUKEE | WI | 53233-2121 | MILWAUKEE | USA | F30CA246920 | Reprogramming tumor-reactive CD8 T cells by targeting the IL-21-BATF pathway to treat melanoma | 000 | 4 | NIH | 1/5/2023 | $51,752 |
|
| Loading… |
|
